Document Detail


A stromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle.
MedLine Citation:
PMID:  21892805     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Although many regenerative cell therapies are being developed to replace or regenerate ischaemic muscle, the lack of vasculature and poor persistence of the therapeutic cells represent major limiting factors to successful tissue restoration. In response to ischaemia, stromal cell-derived factor-1 (SDF-1) is up-regulated by the affected tissue to stimulate stem cell-mediated regenerative responses. Therefore, we encapsulated SDF-1 into alginate microspheres and further incorporated these into an injectable collagen-based matrix in order to improve local delivery. Microsphere-matrix impregnation reduced the time for matrix thermogelation, and also increased the viscosity reached. This double-incorporation prolonged the release of SDF-1, which maintained adhesive and migratory bioactivity, attributed to chemotaxis in response to SDF-1. In vivo, treatment of ischaemic hindlimb muscle with microsphere-matrix led to increased mobilisation of bone marrow-derived progenitor cells, and also improved recruitment of angiogenic cells expressing the SDF-1 receptor (CXCR4) from bone marrow and local tissues. Both matrix and SDF-1-releasing matrix were successful at restoring perfusion, but SDF-1 treatment appeared to play an earlier role, as evidenced by arterioles that are phenotypically older and by increased angiogenic cytokine production, stimulating the generation of a qualitative microenvironment for a rapid and therefore more efficient regeneration. These results support the release of implanted SDF-1 as a promising method for enhancing progenitor cell responses and restoring perfusion to ischaemic tissues via neovascularisation.
Authors:
D Kuraitis; P Zhang; Y Zhang; D T Padavan; K McEwan; T Sofrenovic; D McKee; J Zhang; M Griffith; X Cao; A Musarò; M Ruel; E J Suuronen
Related Documents :
20597105 - Concise review: hitting the right spot with mesenchymal stromal cells.
19159625 - Mesenchymal stem cells expressing neural antigens instruct a neurogenic cell fate on ne...
15913765 - Matrix-mediated retention of adipogenic differentiation potential by human adult bone m...
11912255 - Spatial and temporally restricted expression of chemokines and chemokine receptors in t...
17127455 - Invasion of the killer b's in type 1 diabetes.
15905525 - A mutant cell with a novel defect in mhc class i quality control.
Publication Detail:
Type:  Journal Article     Date:  2011-09-05
Journal Detail:
Title:  European cells & materials     Volume:  22     ISSN:  1473-2262     ISO Abbreviation:  Eur Cell Mater     Publication Date:  2011  
Date Detail:
Created Date:  2011-09-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100973416     Medline TA:  Eur Cell Mater     Country:  Scotland    
Other Details:
Languages:  eng     Pagination:  109-23     Citation Subset:  IM    
Affiliation:
Division of Cardiac Surgery, University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa K1Y4W7, Canada.esuuronen@ottawaheart.ca.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The influence of nutrient supply and cell density on the growth and survival of intervertebral disc ...
Next Document:  The effect of synthetic octacalcium phosphate in a collagen scaffold on the osteogenicity of mesench...